Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022 63 3
Etesevimab Potential treatment - clinical evidence Experimental Antiviral Oct/15/2022 7 18
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Oct/15/2022 15 20
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022 57 5
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 4
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 13 0
Ombitasvir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 1 0
Paritaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 5 0
Excel (.xslx) CSV (.csv)